Skip to main content
Tianjin Ringpu Bio-Technology Co.,Ltd. logo

Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300119 ISIN · CNE100000TV1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,285 across all filing types
Latest filing 2021-11-09 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 300119

About Tianjin Ringpu Bio-Technology Co.,Ltd.

https://www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.

Recent filings

Filing Released Lang Actions
2021年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement of the resolutions passed at the 2021 second extraordinary general meeting of shareholders of Tianjin Ruipu Biotechnology Co., Ltd. It details the voting results on specific proposals, including the election of an independent director and amendments to the company's articles of association. The document includes legal opinions confirming the validity of the meeting and voting procedures. It does not contain financial statements or detailed financial analysis but focuses on the official voting outcomes and meeting details. This matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short and focused on voting results, not a full report or presentation.
2021-11-09 Chinese
关于公司取得新兽药注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the acquisition of a new veterinary drug registration certificate by a subsidiary. It contains no financial data, no regulatory form references, no meeting or voting information, and no financial results. The content is a regulatory announcement about a product approval, not a financial report or meeting material. The document length is short (998 characters) and it is an announcement of a certificate obtained, not a report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2021-11-05 Chinese
第四届董事会第三十三次会议决议公告
Capital/Financing Update Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of Tianjin Ruipu Biotechnology Co., Ltd. It details decisions about establishing special accounts for raised funds and adjusting investment amounts for projects funded by a specific stock issuance. The document includes voting results and references to compliance with company law and stock exchange guidelines. It does not contain financial statements or detailed financial performance data, nor is it a transcript or presentation. It is an announcement of board decisions related to capital raising and fund allocation, which fits the category of Capital/Financing Update (CAP). The document length is under 5,000 characters and is a meeting resolution announcement, not a full report or financial statement. Therefore, the appropriate classification is CAP with high confidence.
2021-11-03 Chinese
第四届监事会第二十八次会议决议公告
Capital/Financing Update Classification · 95% confidence The document is a resolution announcement from the supervisory board of Tianjin Ruipu Biotechnology Co., Ltd. regarding the adjustment of investment amounts for projects funded by proceeds from a private placement of shares. It includes voting results and details of the adjustments. The document is short (1379 characters) and is an official announcement of a board decision related to capital raising and allocation of funds. It is not a full financial report, audit, or earnings release. It fits best under Capital/Financing Update (CAP) as it updates on the company's fundraising and capital allocation activities.
2021-11-03 Chinese
中国银河证券股份有限公司关于瑞普生物创业板向特定对象发行股票发行过程和认购对象合规性的报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report from China Galaxy Securities Co., Ltd. regarding a specific private placement of shares by Tianjin Ruipu Biotechnology Co., Ltd. It includes comprehensive information about the issuance process, pricing, number of shares issued, investor details, compliance with regulatory approvals, and verification of funds received. The document references regulatory approvals from the China Securities Regulatory Commission and Shenzhen Stock Exchange, detailed investor subscription data, and legal compliance checks. It is not a brief announcement or a simple notification but a full report on the issuance process and compliance. This fits the definition of a Capital/Financing Update (CAP), as it provides an update on the company's fundraising activity and capital structure changes through a private placement of shares.
2021-11-03 Chinese
独立董事对第四届董事会第三十三次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from the independent directors regarding a board meeting decision about adjusting the investment amount of funds raised from a private placement. It references compliance with stock exchange listing rules and company articles but does not contain financial statements or detailed financial data. The document is a formal opinion related to board decisions, not a full report or announcement of voting results. It fits best under Board/Management Information (MANG) as it concerns board-level decisions and opinions.
2021-11-03 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.